نتایج جستجو برای: doxorubicin dr

تعداد نتایج: 108951  

New approach of breast cancer therapy is developed toward combination therapy with agent that have a specific molecular target. Our previous study showed that Citrus aurantifolia lime peels ethanolic extract (CPE) increased the sensitivity of MCF-7 cells againts doxorubicin. This study aims to observe the mechanism of combination CPE and doxorubicin in cell cycle modulation and apoptosis on MCF...

Background: Doxorubicin (DOX) is an anthracyclines antibiotic and is one of the most effective antitumor drugs. However, using this drug is associated with poisoning of healthy tissues. The purpose of this study was to investigate the changes in hematological parameters of male rats exposed to doxorubicin after eight weeks of high-intensity interval training and crocin consumption. Materials a...

ELMIRA BARZEGAR, FARZAD RAHMANI, PARVANEH NAJAFIZADEH, TAYEBEH RASTEGAR, ZAHRA MOUSAVI,

Quercetin is one of the major flavonoids finding in many fruits and vegetables. Quercetin has many health promoting advantages such as improvement of allergic, arthritis disorder, and reduction of cancer and cardiovascular risk. The aim of this study was to examine hepatoprotective effects of quercetin on doxorubicin induced toxicity in animal model. Thirty male Wistar rats (200-230 g) were ran...

Journal: :Circulation 2005
Patrick W Fisher Fadi Salloum Anindita Das Haroon Hyder Rakesh C Kukreja

BACKGROUND Sildenafil, a phosphodiesterase-5 inhibitor, induces cardioprotection against ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels. It is unclear whether sildenafil would provide similar protection from doxorubicin-induced cardiotoxicity. METHODS AND RESULTS Male ICR mice were randomized to 1 of 4 treatments: saline, sildenafil, doxorubicin (5 mg/kg IP), and sil...

Journal: :iranian journal of pharmaceutical research 0
anugerah budipratama adina cancer chemoprevention research center faculty of pharmacy, university of gadjah mada sekip utara ii, yogyakarta, 55281, indonesia fina aryani goenadi cancer chemoprevention research center faculty of pharmacy, university of gadjah mada sekip utara ii, yogyakarta, 55281, indonesia fransiscus feby handoko cancer chemoprevention research center faculty of pharmacy, university of gadjah mada sekip utara ii, yogyakarta, 55281, indonesia dwi ana nawangsari cancer chemoprevention research center faculty of pharmacy, university of gadjah mada sekip utara ii, yogyakarta, 55281, indonesia adam hermawan cancer chemoprevention research center, faculty of pharmacy, universitas gadjah mada riris istighfari jenie cancer chemoprevention research center faculty of pharmacy, university of gadjah mada sekip utara ii, yogyakarta, 55281, indonesia

new approach of breast cancer therapy is developed toward combination therapy with agent that have a specific molecular target. our previous study showed that citrus aurantifolia lime peels ethanolic extract (cpe) increased the sensitivity of mcf-7 cells againts doxorubicin. this study aims to observe the mechanism of combination cpe and doxorubicin in cell cycle modulation and apoptosis on mcf...

Journal: :Molecular cancer research : MCR 2005
Ferdaus Hassan Shamima Islam Mya Mya Mu Hiroyasu Ito Naoki Koide Isamu Mori Tomoaki Yoshida Takashi Yokochi

The effect of lipopolysaccharide on doxorubicin-induced cell death was studied by using mouse RAW 264.7 macrophage cells. Pretreatment with lipopolysaccharide at 10 ng/mL prevented doxorubicin-induced cell death and the inhibition was roughly dependent on the concentration of lipopolysaccharide. Posttreatment with lipopolysaccharide for 1 hour also prevented doxorubicin-induced cell death. Lipo...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Puja Sapra Rhona Stein Jennifer Pickett Zhengxing Qu Serengulam V Govindan Thomas M Cardillo Hans J Hansen Ivan D Horak Gary L Griffiths David M Goldenberg

PURPOSE IMMU-110 is a drug immunoconjugate composed of doxorubicin conjugated to the humanized anti-CD74 monoclonal antibody, hLL1, at a doxorubicin/monoclonal antibody ratio of approximately 8:1 (mol/mol). CD74 is a rapidly internalizing molecule associated with HLA-DR, which has high expression by several tumor types. Here, we describe safety evaluations of IMMU-110 in mice and monkeys as wel...

2015
Bray Denard Andrea Pavia-Jimenez Weina Chen Noelle S. Williams Harris Naina Robert Collins James Brugarolas Jin Ye Irina U Agoulnik

BACKGROUND Doxorubicin has been shown to inhibit proliferation of cancer cells through proteolytic activation of CREB3L1 (cAMP response element binding protein 3-like 1), a transcription factor synthesized as a membrane-bound precursor. Upon doxorubicin treatment, CREB3L1 is cleaved so that the N-terminal domain of the protein can reach the nucleus where it activates transcription of genes that...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Salim Khiati Ilaria Dalla Rosa Carole Sourbier Xuefei Ma V Ashutosh Rao Leonard M Neckers Hongliang Zhang Yves Pommier

PURPOSE Doxorubicin is one of the most effective chemotherapeutic agents. However, up to 30% of the patients treated with doxorubicin suffer from congestive heart failure. The mechanism of doxorubicin cardiotoxicity is likely multifactorial and most importantly, the genetic factors predisposing to doxorubicin cardiotoxicity are unknown. On the basis of the fact that mtDNA lesions and mitochondr...

2013
GABRIELLA BRUM THOMAS CARBONE ERIC STILL VENDITA CORREIA KEVIN SZULAK DAVID CALIANESE CHARLES BEST GARRET CAMMARATA KATELYN HIGGINS FANG JI WEN DI YINSHENG WAN

Doxorubicin has been used clinically to treat various types of cancer, and yet the molecular mode of actions of doxorubicin remains to be fully unraveled. In this study, we investigated the effect of doxorubicin on cultured ovarian cancer cells (CaOV3). MTT assay data showed that doxorubicin inhibits cell proliferation in a time- and dose-dependen...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید